Update on the clinical utility of once-daily tacrolimus in the management of transplantation

References

• Kaplan B Srinivas TR Meier-Kriesche HU Factors associated with long-term renal allograft survival Ther Drug Monit 2002 24 1 36 39 11805720
   PubMed Web of Science ®Google Scholar
• van Boekel GA Kerkhofs CH Hilbrands LB Treatment satisfaction in renal transplant patients taking tacrolimus once daily Clin Ther 2013 35 11 1821 1829. e1 24135441
   PubMed Web of Science ®Google Scholar
• United States Organ Transplantation OPTN/SRTR 2012 Annual Data Report [webpage on the Internet] US Department of Health and Human Services 2014 Available from: http://srtr.transplant.hrsa.gov/annual_reports/2012/flash/2012_SRTR_ADR/index.html Accessed June 6, 2014
   Google Scholar
• Ho ET Wong G Craig JC Chapman JR Once-daily extended-release versus twice-daily standard-release tacrolimus in kidney transplant recipients: a systematic review Transplantation 2013 95 9 1120 1128 23542469
   PubMed Web of Science ®Google Scholar
• Barraclough KA Isbel NM Johnson DW Campbell SB Staatz CE Once- versus twice-daily tacrolimus: are the formulations truly equivalent? Drugs 2011 71 12 1561 1577 21861541
   PubMed Web of Science ®Google Scholar
• Tsunashima D Kawamura A Murakami M Assessment of tacrolimus absorption from the human intestinal tract: open-label, randomized, 4-way crossover study Clin Ther 2014 36 5 748 759 24680768
   PubMed Web of Science ®Google Scholar
• First MR Fitzsimmons WE Modified release tacrolimus Yonsei Med J 2004 45 6 1127 1131 15627307
   PubMed Web of Science ®Google Scholar
• Tsuchiya T Ishida H Tanabe T Comparison of pharmacokinetics and pathology for low-dose tacrolimus once-daily and twice-daily in living kidney transplantation: prospective trial in once-daily versus twice-daily tacrolimus Transplantation 2013 96 2 198 204 23792649
   PubMed Web of Science ®Google Scholar
• Gaber AO Alloway RR Bodziak K Kaplan B Bunnapradist S Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients Transplantation 2013 96 2 191 197 23715050
   PubMed Web of Science ®Google Scholar
• Alloway RR Eckhoff DE Washburn WK Teperman LW Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients Liver Transpl 2014 20 5 564 575 24493215
   PubMed Web of Science ®Google Scholar
• Min SI Ha J Kang HG Conversion of twice-daily tacrolimus to once-daily tacrolimus formulation in stable pediatric kidney transplant recipients: pharmacokinetics and efficacy Am J Transplant 2013 13 8 2191 2197 23734831
   PubMed Web of Science ®Google Scholar
• Lapeyraque AL Kassir N Théorêt Y Conversion from twice- to once-daily tacrolimus in pediatric kidney recipients: a pharmacokinetic and bioequivalence study Pediatr Nephrol 2014 29 6 1081 1088 24435759
   PubMed Web of Science ®Google Scholar
• Méndez A Berastegui C López-Meseguer M Pharmacokinetic study of conversion from tacrolimus twice-daily to tacrolimus once-daily in stable lung transplantation Transplantation 2014 97 3 358 362 24492423
   PubMed Web of Science ®Google Scholar
• Stifft F Stolk LM Undre N van Hooff JP Christiaans MH Lower variability in 24-hour exposure during once-daily compared to twice-daily tacrolimus formulation in kidney transplantation Transplantation Epub 12 13 2013
   Google Scholar
• Macphee IA Fredericks S Mohamed M Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose- normalized tacrolimus blood concentrations in whites and South Asians Transplantation 2005 79 4 499 502 15729180
   PubMed Web of Science ®Google Scholar
• Niioka T Kagaya H Miura M Pharmaceutical and genetic determinants for interindividual differences of tacrolimus bioavailability in renal transplant recipients Eur J Clin Pharmacol 2013 69 9 1659 1665 23733010
   PubMed Web of Science ®Google Scholar
• Wu MJ Chang CH Cheng CY Reduced variability of tacrolimus trough level in once-daily tacrolimus-based Taiwanese kidney transplant recipients with high-expressive genotype of cytochrome P450 3A5 Transplant Proc 2014 46 2 403 405 24655974
   PubMed Web of Science ®Google Scholar
• Silva HTJr Yang HC Abouljoud M One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients Am J Transplant 2007 7 3 595 608 17217442
   PubMed Web of Science ®Google Scholar
• Krämer BK Charpentier B Bäckman L Tacrolimus Prolonged Release Renal Study Group Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study Am J Transplant 2010 10 12 2632 2643 20840480
   PubMed Web of Science ®Google Scholar
• Srinivas TR Kaplan B Meier-Kriesche HU The noninferiority trial: don’t don’t do it Am J Transplant 2010 10 12 2571 2573 21087412
   PubMed Web of Science ®Google Scholar
• Albano L Banas B Klempnauer JL Glyda M Viklicky O Kamar N Optimising immunoSuppression After Kidney transplantation with ADVAGRAF Study Group OSAKA trial: a randomized, controlled trial comparing tacrolimus QD and BD in kidney transplantation Transplantation 2013 96 10 897 903 23982340
   PubMed Web of Science ®Google Scholar
• Bunnapradist S Ciechanowski K West-Thielke P Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial Am J Transplant 2013 13 3 760 769 23279614
   PubMed Web of Science ®Google Scholar
• Takahashi K Abe R Usuki S So M Safety and efficacy of once-daily modified-release tacrolimus in kidney transplant recipients: interim analysis of multicenter postmarketing surveillance in Japan Transplant Proc 2014 46 2 406 410 24655975
   PubMed Web of Science ®Google Scholar
• Nakamura Y Hama K Katayama H Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients Transplant Proc 2012 44 1 124 127 22310595
   PubMed Web of Science ®Google Scholar
• Lauzurica R Morales JM van Hooff J Study Investigators Renal function and safety in stable kidney transplant recipients converted from immediate-release to prolonged-release tacrolimus Transpl Int 2012 25 1 48 55 21992068
   PubMed Web of Science ®Google Scholar
• Slatinska J Rohal T Wohlfahrtova M Viklicky O Long-term follow-up of stable kidney transplant recipients after conversion from tacrolimus twice daily immediate release to tacrolimus once-daily prolonged release: a large single-center experience Transplant Proc 2013 45 4 1491 1496 23726604
   PubMed Web of Science ®Google Scholar
• Wu SW Tsai HC Tsai PY Hung TW Chang HR Lian JD Conversion to prolonged release tacrolimus formulation in stable kidney transplant recipients Swiss Med Wkly 2013 143 w13850 23986367
   PubMed Web of Science ®Google Scholar
• Masutani K Tsuchimoto A Haruyama N Protocol biopsy findings in living donor kidney transplant patients treated with once-daily or twice-daily tacrolimus formulation Transplant Proc 2014 46 2 395 399 24655972
   PubMed Web of Science ®Google Scholar
• Kitada H Okabe Y Nishiki T One-year follow-up of treatment with once-daily tacrolimus in de novo renal transplant Exp Clin Transplant 2012 10 6 561 567 23082898
   PubMed Web of Science ®Google Scholar
• Trunečka P Boillot O Seehofer D Tacrolimus Prolonged Release Liver Study Group Once-daily prolonged-release tacrolimus (ADVA-GRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation Am J Transplant 2010 10 10 2313 2323 20840481
   PubMed Web of Science ®Google Scholar
• Dumortier J Guillaud O Boillot O Conversion from twice daily tacrolimus to once daily tacrolimus in long-term stable liver transplant recipients: a single-center experience with 394 patients Liver Transpl 2013 19 5 529 533 23483701
   PubMed Web of Science ®Google Scholar
• Weiler N Thrun I Eberlin M Tacrolimus effects and side effects after liver transplantation: is there a difference between immediate and extended release? Transplant Proc 2013 45 6 2321 2325 23953543
   PubMed Web of Science ®Google Scholar
• Giannelli V Rossi M Giusto M Conversion from twice-daily to once-daily Tacrolimus administration in liver transplant patient: results of long term follow-up Eur Rev Med Pharmacol Sci 2013 17 20 2718 2720 24174352
   PubMed Web of Science ®Google Scholar
• Valente G Rinaldi L Sgambato M Piai G Conversion from twice-daily to once-daily tacrolimus in stable liver transplant patients: effectiveness in a real-world setting Transplant Proc 2013 45 3 1273 1275 23622676
   PubMed Web of Science ®Google Scholar
• Meçule A Poli L Nofroni I Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors Transplant Proc 2010 42 4 1317 1319 20534290
   PubMed Web of Science ®Google Scholar
• Sessa A Esposito A Iavicoli G Cardiovascular risk factors in renal transplant patients after switch from standard tacrolimus to prolonged-release tacrolimus Transplant Proc 2012 44 7 1901 1906 22974866
   PubMed Web of Science ®Google Scholar
• Uchida J Iwai T Kabei K Effects of conversion from a twice-daily tacrolimus to a once-daily tacrolimus on glucose metabolism in stable kidney transplant recipients Transplant Proc 2014 46 2 532 536 24656005
   PubMed Web of Science ®Google Scholar
• Kuypers DR Peeters PC Sennesael JJ Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring Transplantation 2013 95 2 333 340 23263559
   PubMed Web of Science ®Google Scholar
• Eberlin M Otto G Krämer I Increased medication compliance of liver transplant patients switched from a twice-daily to a once-daily tacrolimus-based immunosuppressive regimen Transplant Proc 2013 45 6 2314 2320 23726723
   PubMed Web of Science ®Google Scholar
• Doesch AO Mueller S Akyol C Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation Drug Des Devel Ther 2013 7 1253 1258
   PubMed Web of Science ®Google Scholar
• Sapir-Pichhadze R Wang Y Famure O Li Y Kim SJ Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure Kidney Int 2014 85 6 1404 1411 24336032
   PubMed Web of Science ®Google Scholar